Correlation between catalytic activity and protein content for the polymorphically expressed dihydropyrimidine dehydrogenase in human lymphocytes
- 28 September 1995
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 50 (7) , 1015-1020
- https://doi.org/10.1016/0006-2952(95)00231-n
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Human Polymorphism in Drug Metabolism: Mutation in the Dihydropyrimidine Dehydrogenase Gene Results in Exon Skipping and Thymine UracilureaDNA and Cell Biology, 1995
- Potential importance of dihydropyrimidine dehydrogenase (DPD) in cancer chemotherapyPharmacogenetics, 1994
- A new case of dihydropyrimidine dehydrogenase deficiencyJournal of Inherited Metabolic Disease, 1989
- Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity.Journal of Clinical Investigation, 1988
- Dihydropyrimidine dehydrogenase deficiency leading to thymine-uraciluria. An inborn error of pyrimidine metabolismClinica Chimica Acta; International Journal of Clinical Chemistry, 1984
- Elevated urine, blood and cerebrospinal fluid levels of uracil and thymine in a child with dihydrothymine dehydrogenase deficiencyClinica Chimica Acta; International Journal of Clinical Chemistry, 1984
- Degradation of pyrimidines and pyrimidine analogs—Pathways and mutual influencesPharmacology & Therapeutics, 1980
- The activities of thymidine metabolising enzymes during the cell cycle of a human lymphocyte cell line LAZ-007 synchronised by centrifugal elutriationBiochimica et Biophysica Acta (BBA) - General Subjects, 1980
- Degradation of Pyrimidines — Enzymes, Localization and Role in MetabolismBiochemie und Physiologie der Pflanzen, 1978
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970